A novel ensemble approach improves biomarker detection and accuracy in dementia, suggesting significant insights into underlying mechanisms.
Biomarker discovery in neurodegenerative diseases requires robust, interpretable frameworks capable of integrating high-dimensional multi-omics data under low-sample conditions. We propose a novel ensemble approach combining Graph Attention Networks (GAT), MultiOmics Variational AutoEncoder (MOVE), Elastic-net sparse regression, and Storey's False Discovery Rate (FDR). This framework is benchmarked against state-of-the-art methods including DIABLO, MOCAT, AMOGEL, and MOMLIN. We evaluate performance using both simulated multi-omics data and the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Our method demonstrates superior predictive accuracy, feature selection precision, and biological relevance. Biomarker gene maps derived from both datasets are visualized and interpreted, offering insights into latent molecular mechanisms underlying dementia.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: